Concurrent chemoradiotherapy in non-small cell lung cancer
Author:
Publisher
John Wiley & Sons, Ltd
Reference46 articles.
1. A randomised phase II study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial;Ball;Radiotherapy and Oncology,1999
2. A randomised phase II study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial;Ball;Radiotherapy and Oncology,1999
3. A randomised phase II study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial;Ball;Radiotherapy and Oncology,1999
4. A phase III study of thoracic irradiation with or without concomitant cisplatin in locoregional unresectable non small cell lung cancer: a Hoosier Oncology Group Protocol;Ansari;Proceedings of the American Society of Clinical Oncology,1991
5. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing radiotherapy with chemotherapy using PKPD modeling for lung cancer;2022 IEEE 20th Jubilee World Symposium on Applied Machine Intelligence and Informatics (SAMI);2022-03-02
2. Sequential or concomitant chemotherapy with hypofractionated radiotherapy for locally advanced non-small cell lung cancer: a meta-analysis of randomized trials;Journal of Thoracic Disease;2021-11
3. Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy;Radiation Oncology;2021-08-30
4. Endosonography in mediastinal staging of lung cancer: a concise literature review;Video-Assisted Thoracic Surgery;2021-01
5. A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy;Translational Lung Cancer Research;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3